{"id":482834,"date":"2021-04-27T16:33:56","date_gmt":"2021-04-27T20:33:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/"},"modified":"2021-04-27T16:33:56","modified_gmt":"2021-04-27T20:33:56","slug":"sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/","title":{"rendered":"Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy<\/b><\/p>\n<p>BRISBANE, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nSangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today announced upcoming data presentations at the 24<sup>th<\/sup> Annual Meeting of the American Society of Gene &amp; Cell Therapy (ASGCT) being held May 11-14, 2021, in a virtual format.\n<\/p>\n<p>\n\u201cOur zinc finger technology has shown the versatility to have broad applications across a diverse range of therapeutic areas and the upcoming presentations at ASGCT will focus on one area of particularly high unmet need: neurodegenerative diseases,\u201d said Jason Fontenot, Ph.D., Chief Scientific Officer at Sangamo. \u201cThese abstracts show the potential of zinc finger protein transcription factors to modulate expression of targeted genes in ALS and Parkinson\u2019s disease. We are encouraged that these early results demonstrate the specificity, potency and potential of our transcriptional regulation technology as an impactful genomic medicine approach for these difficult-to-treat conditions. We look forward to continuing our research.\u201d\n<\/p>\n<p><b>ASGCT Annual Meeting Presentations:<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><i>Selective repression of C9ORF72 repeat expansion-containing sense and antisense transcripts for the treatment of amyotrophic lateral sclerosis (ALS) \u2013 Abstract #577<br \/>\n<br \/><\/i>Poster Presentation \u2013 Tuesday, May 11; 8:00-10:00 a.m. ET\n<\/li>\n<li><i>Alpha-synuclein repression using zinc finger protein transcription factors \u2013 a novel therapeutic approach for the treatment of Parkinson\u2019s disease \u2013 Abstract #539<br \/>\n<br \/><\/i>Poster Presentation \u2013 Tuesday, May 11; 8:00-10:00 a.m. ET\n<\/li>\n<\/ul>\n<p>\nAll abstracts for the ASGCT Annual Meeting are available on ASGCT\u2019s website.\n<\/p>\n<p><b>About Sangamo Therapeutics <\/b><\/p>\n<p>\nSangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients\u2019 lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sangamo.com&amp;esheet=52419022&amp;newsitemid=20210427006019&amp;lan=en-US&amp;anchor=www.sangamo.com&amp;index=1&amp;md5=02a3fbef11234500953794e5797c39ef\">www.sangamo.com<\/a>.\n<\/p>\n<p><i>Forward-Looking Statements<\/i><\/p>\n<p>\nThis press release contains forward-looking statements based on our current expectations. These forward-looking statements include, without limitation, statements relating to the potential to use zinc finger technology, including zinc finger protein transcription factors, to develop safe, effective and durable therapies. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Our actual results may differ materially and adversely from those expressed. Factors that could cause actual results to differ include, but are not limited to, the research development process, including the results of clinical trials; the unpredictable regulatory approval process for product candidates; the manufacturing of products and product candidates; the commercialization of approved products; and the potential for technological developments that obviate technologies used by Sangamo. There can be no assurance that we will be able to develop and obtain the necessary regulatory approvals for commercially viable products. These risks and uncertainties are described more fully in our Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and we undertake no duty to update such information except as required under applicable laws.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210427006019r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210427006019\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210427006019\/en\/<\/a><\/span><\/p>\n<p><span class=\"bwuline\">Investor Relations &amp; Media Inquiries<br \/>\n<\/span><br \/>Aron Feingold<br \/>\n<br \/>628.252.7494<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:afeingold@sangamo.com\">afeingold@sangamo.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Genetics Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210427006019\/en\/736004\/3\/Sangamo_logoTM.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy BRISBANE, Calif.&#8211;(BUSINESS WIRE)&#8211; Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today announced upcoming data presentations at the 24th Annual Meeting of the American Society of Gene &amp; Cell Therapy (ASGCT) being held May 11-14, 2021, in a virtual format. \u201cOur zinc finger technology has shown the versatility to have broad applications across a diverse range of therapeutic areas and the upcoming presentations at ASGCT will focus on one area of particularly high unmet need: neurodegenerative diseases,\u201d said Jason Fontenot, Ph.D., Chief Scientific Officer at Sangamo. \u201cThese abstracts show the potential of zinc finger protein transcription factors to modulate expression of targeted &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-482834","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy BRISBANE, Calif.&#8211;(BUSINESS WIRE)&#8211; Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today announced upcoming data presentations at the 24th Annual Meeting of the American Society of Gene &amp; Cell Therapy (ASGCT) being held May 11-14, 2021, in a virtual format. \u201cOur zinc finger technology has shown the versatility to have broad applications across a diverse range of therapeutic areas and the upcoming presentations at ASGCT will focus on one area of particularly high unmet need: neurodegenerative diseases,\u201d said Jason Fontenot, Ph.D., Chief Scientific Officer at Sangamo. \u201cThese abstracts show the potential of zinc finger protein transcription factors to modulate expression of targeted &hellip; Continue reading &quot;Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-27T20:33:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210427006019r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy\",\"datePublished\":\"2021-04-27T20:33:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\\\/\"},\"wordCount\":535,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210427006019r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\\\/\",\"name\":\"Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210427006019r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-04-27T20:33:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210427006019r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210427006019r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/","og_locale":"en_US","og_type":"article","og_title":"Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy - Market Newsdesk","og_description":"Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy BRISBANE, Calif.&#8211;(BUSINESS WIRE)&#8211; Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today announced upcoming data presentations at the 24th Annual Meeting of the American Society of Gene &amp; Cell Therapy (ASGCT) being held May 11-14, 2021, in a virtual format. \u201cOur zinc finger technology has shown the versatility to have broad applications across a diverse range of therapeutic areas and the upcoming presentations at ASGCT will focus on one area of particularly high unmet need: neurodegenerative diseases,\u201d said Jason Fontenot, Ph.D., Chief Scientific Officer at Sangamo. \u201cThese abstracts show the potential of zinc finger protein transcription factors to modulate expression of targeted &hellip; Continue reading \"Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-27T20:33:56+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210427006019r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy","datePublished":"2021-04-27T20:33:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/"},"wordCount":535,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210427006019r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/","name":"Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210427006019r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-04-27T20:33:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210427006019r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210427006019r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sangamo-therapeutics-announces-presentations-at-2021-annual-meeting-of-the-american-society-of-gene-cell-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene &amp; Cell Therapy"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/482834","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=482834"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/482834\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=482834"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=482834"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=482834"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}